Home›Stock Screener›Concord Drugs›P/E Ratio

Concord Drugs P/E Ratio

Current P/E Ratio
184.67
High Valuation
Very High - High growth expectations or significantly overvalued

Concord Drugs (CONCORD) P/E ratio is 184.67 (High), EPS (TTM) ₹0.34, current price ₹80.75 on BSE vs historical average P/E of 97.64 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Concord Drugs share price screener.

Current Valuation Metrics

P/E Ratio 184.67
Current Price ₹80.75
EPS (TTM) ₹0.34
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 97.64
Historical Range 33.56 - 161.73
Percentile 100.0%

Sector Context

Sector Average 49.17
Sector Median 29.34
Sector Rank #11 of 190
Sector Percentile 5.8%

Earnings Breakdown (TTM)

TTM EPS ₹0.51
Sept 2025 ₹0.19
Mar 2025 ₹0.04

CONCORD P/E Ratio — Valuation Signal & Historical Context

Concord Drugs P/E 184.67 vs historical average 97.64, range 33.56–161.73 — signal: Overvalued. Analyse Concord Drugs ownership structure to track promoter, FII and institutional holdings.

  • Stock appears overvalued with PE of 184.67, suggesting caution for new investments
  • Current PE is 89.1% above historical average
  • Trading at premium to sector average PE of 49.17

Concord Drugs P/E Ratio Historical Trend

CONCORD annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 184.67 vs historical average 97.64. Browse CONCORD balance sheet details for revenue, profit, balance sheet and cash flow data.

CONCORD Historical P/E Ratio — EPS, Year-End Price & Valuation

Concord Drugs annual P/E ratio, EPS (₹), year-end price and valuation category on BSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 161.73 0.51 ₹82.48 BSE High
2022 33.56 0.97 ₹32.55 BSE High

CONCORD vs Healthcare Peers — P/E Ratio Comparison

Concord Drugs P/E 184.67 vs Healthcare average 49.17, median 29.34 — range 1.0–869.57.

Sector Average
49.17
Sector Median
29.34
Lowest P/E
1.0
Highest P/E
869.57
Companies
190
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.0 ₹36 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.45 ₹61 Low
Ind Swift Laboratories INDSWFTLAB 4.69 ₹1,161 Low
Amwill Health Care AMWILL 6.34 ₹65 Low
Brooks Laboratories BROOKS 6.6 ₹137 Low
Mono Pharmacare MONOPHARMA 7.1 ₹21 Low
Shelter Pharma SHELTER 7.4 ₹54 Low
Medicamen Organics MEDIORG 7.51 ₹32 Low
Zenith Drugs ZENITHDRUG 7.69 ₹66 Low